Microdosimetry for targeted alpha therapy of cancer

Computational and Mathematical Methods in Medicine

Volumn 2012, Issue , 2012, Pages

  Huang, Chen Yu ^a   Guatelli, Susanna ^b   Oborn, Bradley M ^b,c   Allen, Barry J ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Illawarra Cancer Care Centre   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; DISEASES;

ALPHA RADIATION; ANTIGEN EXPRESSION; BIOLOGICAL FACTORS; CELL SENSITIVITY; MICRODOSIMETRIC CALCULATIONS; TARGET CONFIGURATIONS; THERAPEUTIC DOSE; THERAPEUTIC EFFICACY;

CELLS;

ACTINIUM 225; ASTATINE 211; BISMUTH 213; RADIOISOTOPE; RADIUM CHLORIDE RA 223;

ARTICLE; CANCER CELL; CANCER THERAPY; CELL SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; GEOMETRY; HUMAN; IRRADIATION; METASTATIC MELANOMA; MICRODOSIMETRY; RADIATION DOSE; RADIOIMMUNOTHERAPY; TARGETED ALPHA THERAPY; ALPHA RADIATION; ANIMAL; ANOXIA; CELL NUCLEUS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER SIMULATION; DNA DAMAGE; DNA REPAIR; KINETICS; METABOLISM; METHODOLOGY; MONTE CARLO METHOD; NEOPLASM; RADIOMETRY; RADIOTHERAPY; REPRODUCIBILITY; STATISTICS;

ALPHA PARTICLES; ANIMALS; ANOXIA; CELL NUCLEUS; COMPUTER SIMULATION; DNA DAMAGE; DNA REPAIR; HUMANS; KINETICS; MONTE CARLO METHOD; NEOPLASMS; RADIOISOTOPES; RADIOMETRY; RADIOTHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; STOCHASTIC PROCESSES;

EID: 84867018910     PISSN: 1748670X     EISSN: 17486718     Source Type: Journal    
DOI: 10.1155/2012/153212     Document Type: Article

References (47)

1. Zalutsky M. R., Pozzi O. R., Radioimmunotherapy with α -particle emitting radionuclides. Quarterly Journal of Nuclear Medicine and Molecular Imaging 2004 48 4 289 296 2-s2.0-15944427877
2. Rajkumar V., Dearling J. L., Packard A., Pedley R. B., Research Spotlightradioimmunotherapy: optimizing delivery to solid tumors. Therapeutic Delivery 2011 2 5 567 572 2-s2.0-79956103070 10.4155/tde.11.33
3. Sgouros G., Alpha-particles for targeted therapy. Advanced Drug Delivery Reviews 2008 60 12 1402 1406 2-s2.0-46949111791 10.1016/j.addr.2008.04.007
4. Roeske J. C., Stinchcomb T. G., Dosimetric framework for therapeutic alpha-particle emitters. Journal of Nuclear Medicine 1997 38 12 1923 1929 2-s2.0-0031442829 (Pubitemid 28030924)
5. McDevitt M. R., Sgouros G., Finn R. D., Humm J. L., Jurcic J. G., Larson S. M., Scheinberg D. A., Radioimmunotherapy with alpha-emitting nuclides. European Journal of Nuclear Medicine 1998 25 9 1341 1351 2-s2.0-0031715792 10.1007/s002590050306 (Pubitemid 28446064)
6. Jurcic J. G., Larson S. M., Sgouros G., McDevitt M. R., Finn R. D., Divgi C. R., Targeted α particle immunotherapy for myeloid leukemia. Blood 2002 100 4 1233 1239 2-s2.0-0037103293 (Pubitemid 34864277)
7. Raja C., Graham P., Abbas Rizvi S. M., Song E., Goldsmith H., Thompson J., Bosserhoff A., Morgenstern A., Apostolidis C., Kearsley J., Reisfeld R., Allen B. J., Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma. Cancer Biology and Therapy 2007 6 6 846 852 2-s2.0-38049170147 (Pubitemid 351574972)
8. Allen B. J., Raja C., Rizvi S., Song E. Y., Graham P., Tumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancer. Physics in Medicine and Biology 2007 52 13 L15 L19 2-s2.0-34250363163 10.1088/0031-9155/52/13/L01 (Pubitemid 46908610)
9. Allen B. J., Can α -radioimmunotherapy increase efficacy for the systemic control of cancer? Immunotherapy 2011 3 4 455 458 2-s2.0-79953828095 10.2217/imt.11.13
10. Bardies M., Pihet P., Dosimetry and microdosimetry of targeted radiotherapy. Current Pharmaceutical Design 2000 6 14 1469 1502 2-s2.0-0033863161
11. Hobbs R. F., Baechler S., Fu D. X., Esaias C., Pomper M. G., Ambinder R. F., Sgouros G., A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy. Medical Physics 2011 38 6 2892 2903 2-s2.0-79958850515 10.1118/1.3576051
12. Karagiannis T. C., Comparison of different classes of radionuclides for potential use in radioimmunotherapy. Hellenic Journal of Nuclear Medicine 2007 10 2 82 88 (Pubitemid 47342270)
13. Macklis R. M., Kinsey B. M., Kassis A. I., Ferrara J. L. M., Atcher R. W., Hines J. J., Coleman C. N., Adelstein S. J., Burakoff S. J., Radioimmunotherapy with alpha-particle-emitting immunoconjugates. Science 1988 240 4855 1024 1026 2-s2.0-0024292678
14. Zaidi H., Sgouros G., Therapeutic Applications of Monte Carlo Calculations in Nuclear Medicine 2003 9, vol. 30 London, UK Institute of physics
15. Stinchcomb T. G., Roeske J. C., Analytic microdosimetry for radioimmunotherapeutic alpha emitters. Medical Physics 1992 19 6 1385 1394 2-s2.0-0026454246 10.1118/1.596770
16. McDevitt M. R., Sgouros G., Finn R. D., Humm J. L., Jurcic J. G., Larson S. M., Scheinberg D. A., Radioimmunotherapy with alpha-emitting nuclides. European Journal of Nuclear Medicine 1998 25 9 1341 1351 2-s2.0-0031715792 10.1007/s002590050306 (Pubitemid 28446064)
17. Sofou S., Radionuclide carriers for targeting of cancer. International Journal of Nanomedicine 2008 3 2 181 199 2-s2.0-68549101438 (Pubitemid 352037851)
18. Goodhead D. T., Panel discussion: do non-targeted effects impact the relation between microdosimetry and risk? Radiation Protection Dosimetry 2011 143 24 554 556 2-s2.0-79952336269 10.1093/rpd/ncq393
19. Huang C. Y., Oborn B. M., Guatelli S., Allen B. J., Monte Carlo calculation of the maximum therapeutic gain of tumor antivascular alpha therapy. Medical Physics 2012 39 3 1282 1288
20. Humm J. L., Roeske J. C., Fisher D. R., Chen G. T. Y., Microdosimetric concepts in radioimmunotherapy. Medical Physics 1993 20 2 535 542 2-s2.0-0027211856 10.1118/1.597049 (Pubitemid 23134003)
21. Goodhead D. T., Energy deposition stochastics and track structure: what about the target? Radiation Protection Dosimetry 2006 122 14 3 15 2-s2.0-34347368952 10.1093/rpd/ncl498 (Pubitemid 47090415)
22. Charlton D. E., Kassis A. I., Adelstein S. J., A comparison of experimental and calculated survival curves for V79 cells grown as monolayers or in suspension exposed to alpha irradiation from 212Bi distributed in the growth medium. Radiation Protection Dosimetry 1994 52 14 311 315 2-s2.0-0028204813 (Pubitemid 24120352)
23. Roesch W. C., Microdosimetry of internal sources. Radiation Research 1977 70 3 494 510 2-s2.0-0017638164 (Pubitemid 8142726)
24. Rosenfeld A. B., Kaplan G. I., Carolan M. G., Alien B. J., Maughan R., Yudelev M., Kota C., Coderre J., Simultaneous macro and micro dosimetry with MOSFETs. IEEE Transactions on Nuclear Science 1996 43 6 2693 2700 2-s2.0-0030365376 (Pubitemid 126770919)
25. Bradley P. D., Rosenfeld A. B., Tissue equivalence correction for silicon microdosimetry detectors in boron neutron capture therapy. Medical Physics 1998 25 11 2220 2225 2-s2.0-0031769698 10.1118/1.598421 (Pubitemid 28530114)
26. Bradley P. D., Rosenfeld A. B., Allen B., Coderre J., Capala J., Performance of silicon microdosimetry detectors in boron neutron capture therapy. Radiation Research 1999 151 3 235 243 2-s2.0-0032976612 (Pubitemid 29109133)
27. Incerti S., Gault N., Habchi C., Lefaix J. L., Moretto P., Poncy J. L., Pouthier T., Seznec H., A comparison of cellular irradiation techniques with alpha particles using the Geant4 Monte Carlo simulation toolkit. Radiation Protection Dosimetry 2006 122 14 327 329 2-s2.0-34347391923 10.1093/rpd/ncl422 (Pubitemid 47090476)
28. Huang C. Y., Guatelli S., Oborn B. M., Allen B. J., Background dose for systemic targeted Alpha therapy. Progress in Nuclear Science and Technology 2011 2 187 190
29. Rosenblat T. L., McDevitt M. R., Mulford D. A., Pandit-Taskar N., Divgi C. R., Panageas K. S., Heaney M. L., Chanel S., Morgenstern A., Sgouros G., Larson S. M., Scheinberg D. A., Jurcic J. G., Sequential cytarabine and α -particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia. Clinical Cancer Research 2010 16 21 5303 5311 2-s2.0-78049456138 10.1158/1078-0432.CCR-10-0382
30. Nikjoo H., Uehara S., Emfietzoglou D., Pinsky L., A database of frequency distributions of energy depositions in small-size targets by electrons and ions. Radiation Protection Dosimetry 2011 143 24 145 151 2-s2.0-79952318650 10.1093/rpd/ncq396
31. Humm J. L., Chin L. M., A model of cell inactivation by alpha-particle internal emitters. Radiation Research 1993 134 2 143 150 2-s2.0-0027158017 10.2307/3578453 (Pubitemid 23157439)
32. Kennel S. J., Boll R., Stabin M., Schuller H. M., Mirzadeh S., Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi. British Journal of Cancer 1999 80 1-2 175 184 2-s2.0-0032922203 (Pubitemid 29210104)
33. Charlton D. E., The survival of monolayers of cells growing in clusters irradiated by 211At appended to the cell surfaces. Radiation Research 1999 151 6 750 753 2-s2.0-0033044903 10.2307/3580215 (Pubitemid 29252564)
34. Kvinnsland Y., Stokke T., Aurlien E., Radioimmunotherapy with alpha-particle emitters: microdosimetry of cell with a heterogeneous antigen expression and with various diameters of cells and nuclei. Radiation Research 2001 155 2 288 296 2-s2.0-0035141515 (Pubitemid 32125979)
35. Incerti S., Seznec H., Simon M., Barberet P., Habchi C., Moretto P., Monte Carlo dosimetry for targeted irradiation of individual cells using a microbeam facility. Radiation Protection Dosimetry 2009 133 1 2 11 2-s2.0-61449252569 10.1093/rpd/ncp003
36. Kennel S. J., Stabin M., Roeske J. C., Foote L. J., Lankford P. K., Terzaghi-Howe M., Patterson H., Barkenbus J., Popp D. M., Boll R., Mirzadeh S., Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cells. Radiation Research 1999 151 3 244 256 2-s2.0-0032976272 (Pubitemid 29109134)
37. Chouin N., Bernardeau K., Davodeau F., Chérel M., Faivre-Chauvet A., Bourgeois M., Apostolidis C., Morgenstern A., Lisbona A., Bardis M., Evidence of extranuclear cell sensitivity to alpha-particle radiation using a microdosimetric modelI. Presentation and validation of a microdosimetric model. Radiation Research 2009 171 6 657 663 2-s2.0-67849092565 10.1667/RR1371.1
38. Yao Z., Garmestani K., Wong K. J., Park L. S., Dadachova E., Yordanov A., Waldmann T. A., Eckelman W. C., Paik C. H., Carrasquillo J. A., Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody. Journal of Nuclear Medicine 2001 42 10 1538 1544 2-s2.0-0034786178 (Pubitemid 32953135)
39. Sgouros G., Roeske J. C., McDevitt M. R., Palm S., Allen B. J., Fisher D. R., Brill A. B., Song H., Howell R. W., Akabani G., Bolch W. E., Meredith R. F., Wessels B. W., Zanzonico P. B., MIRD pamphlet No. 22 (Abridged): Radiobiology and dosimetry of α -particle emitters for targeted radionuclide therapy. Journal of Nuclear Medicine 2010 51 2 311 328 2-s2.0-75749110617 10.2967/jnumed.108.058651
40. Pohlman B., Sweetenham J., Macklis R. M., Review of clinical radioimmunotherapy. Expert Review of Anticancer Therapy 2006 6 3 445 461 2-s2.0-33644911467 10.1586/14737140.6.3.445 (Pubitemid 44192926)
41. Nilsson S., Larsen R. H., Fosså S. D., Balteskard L., Borch K. W., Westlin J. E., Salberg G., Bruland O. S., First clinical experience with α -emitting radium-223 in the treatment of skeletal metastases. Clinical Cancer Research 2005 11 12 4451 4459 2-s2.0-20644447798 10.1158/1078-0432.CCR-04-2244 (Pubitemid 40834252)
42. Allen B. J., Clinical trials of targeted alpha therapy for cancer. Reviews on Recent Clinical Trials 2008 3 3 185 191 2-s2.0-54049137660 10.2174/157488708785700339
43. Zhu X., Palmer M. R., Makrigiorgos G. M., Kassis A. I., Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis. Medical Physics 2010 37 6 2974 2984 2-s2.0-77953511570 10.1118/1.3431999
44. Kassis A. I., Therapeutic radionuclides: biophysical and radiobiologic principles. Seminars in Nuclear Medicine 2008 38 5 358 366 2-s2.0-47749154422 10.1053/j.semnuclmed.2008.05.002 (Pubitemid 352033559)
45. McDevitt M. R., Ma D., Lai L. T., Simon J., Borchardt P., Frank R. K., Wu K., Pellegrini V., Curcio M. J., Miederer M., Bander N. H., Scheinberg D. A., Tumor therapy with targeted atomic nanogenerators. Science 2001 294 5546 1537 1540 2-s2.0-0035900395 10.1126/science.1064126 (Pubitemid 33063927)
46. Schwartz J., Jaggi J. S., O'donoghue J. A., Ruan S., McDevitt M., Larson S. M., Scheinberg D. A., Humm J. L., Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody. Physics in Medicine and Biology 2011 56 3 721 733 2-s2.0-79551705078 10.1088/0031-9155/56/3/012
47. Ballangrud Å. M., Yang W. H., Palm S., Enmon R., Borchardt P. E., Pellegrini V. A., McDevitt M. R., Scheinberg D. A., Sgouros G., Alpha-particle emitting atomic generator (actinium-225)-labeled trastuzumab (Herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression. Clinical Cancer Research 2004 10 13 4489 4497 2-s2.0-3042729733 10.1158/1078-0432.CCR-03-0800 (Pubitemid 38878893)